11.47
+0.07
+(0.61%)
At close: April 15 at 4:00:00 PM EDT
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 21 | 20 |
| Avg. Estimate | -- | -- | 3.59B | 5.47B |
| Low Estimate | -- | -- | 2.98B | 4.56B |
| High Estimate | -- | -- | 4.28B | 6.52B |
| Year Ago Sales | -- | -- | 2.12B | 3.59B |
| Sales Growth (year/est) | -- | -- | 69.04% | 52.48% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| AKESF | -- | -- | -- | -- |
| S&P 500 | 6.79% | 5.59% | 9.06% | 14.11% |
Related Tickers
CGON CG Oncology, Inc.
20.22
+0.55%
ZBIO Zenas BioPharma, Inc.
8.33
-4.47%
TIL Instil Bio, Inc.
15.30
-7.16%
ACLX Arcellx, Inc.
60.69
-1.20%
MLYS Mineralys Therapeutics, Inc.
13.50
-2.74%
BV3A.F Bavarian Nordic A/S
6.65
0.00%
B9A.BE BioArctic AB
19.00
+14.46%
ZVA.F Cellectis S.A.
1.3180
-4.22%
1AEA.SG argenx SE
505.00
-3.81%
BV3.BE Bavarian Nordic A/S
20.15
-0.30%